EXPO vs ECG
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 04, 2026
EXPO
ECG
Investment Advisor Scores
ECG
AI Analyst Insights
Detailed Metrics Comparison
| Metric | EXPO | ECG | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 31.5457 | 16.1031 | ECG |
| PEG Ratio | 2.0325 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 11.7% | 33.7% | ECG |
| Earnings Growth | 16.4% | 59.2% | ECG |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 44.1/100 | 50.0/100 | ECG |
| Profit Margin | 19.7% | 6.0% | EXPO |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
EXPO
MarkupPrice above SMA50, rising 50-day trend (6.3% over 20 days), RSI 73
ECG
MarkdownPrice below a falling SMA50 (slope -10.3%), weak momentum, RSI 42
Fundamentals Snapshot
| Metric | EXPO | ECG |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 29.5 | 12.7 |
| Trailing P/E | 37.1 | 14.9 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.4% |
| Gross Margin | 0.4% | 0.1% |
| Operating Margin | 0.3% | 0.1% |
| EPS | 2.32 | 5.74 |
| Dividend Yield | 0.01% | — |